nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—Melaena—Epirubicin—liver cancer	0.00291	0.00412	CcSEcCtD
Galantamine—Cystitis noninfective—Epirubicin—liver cancer	0.00291	0.00412	CcSEcCtD
Galantamine—Salivary hypersecretion—Epirubicin—liver cancer	0.0029	0.0041	CcSEcCtD
Galantamine—Bone pain—Doxorubicin—liver cancer	0.00288	0.00408	CcSEcCtD
Galantamine—Cystitis—Epirubicin—liver cancer	0.00288	0.00408	CcSEcCtD
Galantamine—Atrioventricular block—Doxorubicin—liver cancer	0.00285	0.00403	CcSEcCtD
Galantamine—Shock—Sorafenib—liver cancer	0.00283	0.00401	CcSEcCtD
Galantamine—Nervous system disorder—Sorafenib—liver cancer	0.00283	0.004	CcSEcCtD
Galantamine—Thrombocytopenia—Sorafenib—liver cancer	0.00282	0.00399	CcSEcCtD
Galantamine—Blood urea increased—Epirubicin—liver cancer	0.00282	0.00399	CcSEcCtD
Galantamine—Skin disorder—Sorafenib—liver cancer	0.0028	0.00396	CcSEcCtD
Galantamine—Hiccups—Doxorubicin—liver cancer	0.00276	0.00391	CcSEcCtD
Galantamine—Ventricular tachycardia—Doxorubicin—liver cancer	0.00276	0.00391	CcSEcCtD
Galantamine—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00276	0.00391	CcSEcCtD
Galantamine—Anorexia—Sorafenib—liver cancer	0.00275	0.00388	CcSEcCtD
Galantamine—Cramps of lower extremities—Epirubicin—liver cancer	0.00274	0.00388	CcSEcCtD
Galantamine—Bladder pain—Epirubicin—liver cancer	0.0027	0.00382	CcSEcCtD
Galantamine—Melaena—Doxorubicin—liver cancer	0.0027	0.00382	CcSEcCtD
Galantamine—Cystitis noninfective—Doxorubicin—liver cancer	0.0027	0.00382	CcSEcCtD
Galantamine—Salivary hypersecretion—Doxorubicin—liver cancer	0.00268	0.00379	CcSEcCtD
Galantamine—Cystitis—Doxorubicin—liver cancer	0.00267	0.00377	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00262	0.00371	CcSEcCtD
Galantamine—Hypertonia—Epirubicin—liver cancer	0.00262	0.0037	CcSEcCtD
Galantamine—Blood urea increased—Doxorubicin—liver cancer	0.00261	0.00369	CcSEcCtD
Galantamine—Cramps of lower extremities—Doxorubicin—liver cancer	0.00254	0.00359	CcSEcCtD
Galantamine—Dyspepsia—Sorafenib—liver cancer	0.00254	0.00359	CcSEcCtD
Galantamine—Decreased appetite—Sorafenib—liver cancer	0.0025	0.00354	CcSEcCtD
Galantamine—Bladder pain—Doxorubicin—liver cancer	0.0025	0.00353	CcSEcCtD
Galantamine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00249	0.00352	CcSEcCtD
Galantamine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00249	0.00352	CcSEcCtD
Galantamine—Fatigue—Sorafenib—liver cancer	0.00248	0.00351	CcSEcCtD
Galantamine—Constipation—Sorafenib—liver cancer	0.00246	0.00349	CcSEcCtD
Galantamine—Vascular purpura—Epirubicin—liver cancer	0.00242	0.00343	CcSEcCtD
Galantamine—Hypertonia—Doxorubicin—liver cancer	0.00242	0.00342	CcSEcCtD
Galantamine—Gastrointestinal pain—Sorafenib—liver cancer	0.00236	0.00333	CcSEcCtD
Galantamine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.0023	0.00326	CcSEcCtD
Galantamine—Abdominal pain—Sorafenib—liver cancer	0.00228	0.00322	CcSEcCtD
Galantamine—Body temperature increased—Sorafenib—liver cancer	0.00228	0.00322	CcSEcCtD
Galantamine—Renal impairment—Epirubicin—liver cancer	0.00228	0.00322	CcSEcCtD
Galantamine—Purpura—Epirubicin—liver cancer	0.00225	0.00318	CcSEcCtD
Galantamine—Vascular purpura—Doxorubicin—liver cancer	0.00224	0.00317	CcSEcCtD
Galantamine—Cardiac failure—Epirubicin—liver cancer	0.00222	0.00314	CcSEcCtD
Galantamine—Lethargy—Epirubicin—liver cancer	0.00221	0.00313	CcSEcCtD
Galantamine—Cerebrovascular accident—Epirubicin—liver cancer	0.00221	0.00313	CcSEcCtD
Galantamine—Pain in extremity—Epirubicin—liver cancer	0.00217	0.00306	CcSEcCtD
Galantamine—Hypersensitivity—Sorafenib—liver cancer	0.00212	0.003	CcSEcCtD
Galantamine—Renal impairment—Doxorubicin—liver cancer	0.00211	0.00298	CcSEcCtD
Galantamine—Purpura—Doxorubicin—liver cancer	0.00208	0.00294	CcSEcCtD
Galantamine—Asthenia—Sorafenib—liver cancer	0.00207	0.00292	CcSEcCtD
Galantamine—Cardiac failure—Doxorubicin—liver cancer	0.00205	0.00291	CcSEcCtD
Galantamine—Cerebrovascular accident—Doxorubicin—liver cancer	0.00205	0.00289	CcSEcCtD
Galantamine—Lethargy—Doxorubicin—liver cancer	0.00205	0.00289	CcSEcCtD
Galantamine—Ataxia—Epirubicin—liver cancer	0.00204	0.00288	CcSEcCtD
Galantamine—Dehydration—Epirubicin—liver cancer	0.00201	0.00285	CcSEcCtD
Galantamine—Pain in extremity—Doxorubicin—liver cancer	0.002	0.00284	CcSEcCtD
Galantamine—Orthostatic hypotension—Epirubicin—liver cancer	0.00198	0.0028	CcSEcCtD
Galantamine—Abdominal pain upper—Epirubicin—liver cancer	0.00198	0.0028	CcSEcCtD
Galantamine—Hypokalaemia—Epirubicin—liver cancer	0.00197	0.00279	CcSEcCtD
Galantamine—Diarrhoea—Sorafenib—liver cancer	0.00197	0.00279	CcSEcCtD
Galantamine—Gastritis—Epirubicin—liver cancer	0.00192	0.00271	CcSEcCtD
Galantamine—Muscular weakness—Epirubicin—liver cancer	0.00191	0.0027	CcSEcCtD
Galantamine—Dizziness—Sorafenib—liver cancer	0.0019	0.00269	CcSEcCtD
Galantamine—Ataxia—Doxorubicin—liver cancer	0.00188	0.00267	CcSEcCtD
Galantamine—Dysphagia—Epirubicin—liver cancer	0.00187	0.00265	CcSEcCtD
Galantamine—Dehydration—Doxorubicin—liver cancer	0.00186	0.00264	CcSEcCtD
Galantamine—Vomiting—Sorafenib—liver cancer	0.00183	0.00259	CcSEcCtD
Galantamine—Abdominal pain upper—Doxorubicin—liver cancer	0.00183	0.00259	CcSEcCtD
Galantamine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00183	0.00259	CcSEcCtD
Galantamine—Hypokalaemia—Doxorubicin—liver cancer	0.00182	0.00258	CcSEcCtD
Galantamine—Rash—Sorafenib—liver cancer	0.00182	0.00257	CcSEcCtD
Galantamine—Dermatitis—Sorafenib—liver cancer	0.00181	0.00257	CcSEcCtD
Galantamine—Headache—Sorafenib—liver cancer	0.0018	0.00255	CcSEcCtD
Galantamine—Bronchitis—Epirubicin—liver cancer	0.0018	0.00255	CcSEcCtD
Galantamine—Gastritis—Doxorubicin—liver cancer	0.00177	0.00251	CcSEcCtD
Galantamine—Muscular weakness—Doxorubicin—liver cancer	0.00177	0.0025	CcSEcCtD
Galantamine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00174	0.00246	CcSEcCtD
Galantamine—Dysphagia—Doxorubicin—liver cancer	0.00173	0.00245	CcSEcCtD
Galantamine—Pollakiuria—Epirubicin—liver cancer	0.00173	0.00245	CcSEcCtD
Galantamine—Nausea—Sorafenib—liver cancer	0.00171	0.00242	CcSEcCtD
Galantamine—Weight decreased—Epirubicin—liver cancer	0.00169	0.0024	CcSEcCtD
Galantamine—Hyperglycaemia—Epirubicin—liver cancer	0.00169	0.00239	CcSEcCtD
Galantamine—Pneumonia—Epirubicin—liver cancer	0.00168	0.00238	CcSEcCtD
Galantamine—Bronchitis—Doxorubicin—liver cancer	0.00167	0.00236	CcSEcCtD
Galantamine—Renal failure—Epirubicin—liver cancer	0.00164	0.00232	CcSEcCtD
Galantamine—Neuropathy peripheral—Epirubicin—liver cancer	0.00164	0.00231	CcSEcCtD
Galantamine—Urinary tract infection—Epirubicin—liver cancer	0.00162	0.0023	CcSEcCtD
Galantamine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00161	0.00228	CcSEcCtD
Galantamine—Pollakiuria—Doxorubicin—liver cancer	0.0016	0.00226	CcSEcCtD
Galantamine—Haematuria—Epirubicin—liver cancer	0.00159	0.00225	CcSEcCtD
Galantamine—Hepatobiliary disease—Epirubicin—liver cancer	0.00158	0.00223	CcSEcCtD
Galantamine—Epistaxis—Epirubicin—liver cancer	0.00157	0.00223	CcSEcCtD
Galantamine—Weight decreased—Doxorubicin—liver cancer	0.00157	0.00222	CcSEcCtD
Galantamine—Hyperglycaemia—Doxorubicin—liver cancer	0.00156	0.00221	CcSEcCtD
Galantamine—Pneumonia—Doxorubicin—liver cancer	0.00155	0.0022	CcSEcCtD
Galantamine—Bradycardia—Epirubicin—liver cancer	0.00153	0.00216	CcSEcCtD
Galantamine—Renal failure—Doxorubicin—liver cancer	0.00152	0.00215	CcSEcCtD
Galantamine—Neuropathy peripheral—Doxorubicin—liver cancer	0.00151	0.00214	CcSEcCtD
Galantamine—Haemoglobin—Epirubicin—liver cancer	0.00151	0.00213	CcSEcCtD
Galantamine—Rhinitis—Epirubicin—liver cancer	0.0015	0.00213	CcSEcCtD
Galantamine—Urinary tract infection—Doxorubicin—liver cancer	0.0015	0.00212	CcSEcCtD
Galantamine—Haemorrhage—Epirubicin—liver cancer	0.0015	0.00212	CcSEcCtD
Galantamine—Hepatitis—Epirubicin—liver cancer	0.0015	0.00212	CcSEcCtD
Galantamine—Urinary tract disorder—Epirubicin—liver cancer	0.00148	0.00209	CcSEcCtD
Galantamine—Oedema peripheral—Epirubicin—liver cancer	0.00148	0.00209	CcSEcCtD
Galantamine—Haematuria—Doxorubicin—liver cancer	0.00147	0.00208	CcSEcCtD
Galantamine—Connective tissue disorder—Epirubicin—liver cancer	0.00147	0.00208	CcSEcCtD
Galantamine—Urethral disorder—Epirubicin—liver cancer	0.00147	0.00208	CcSEcCtD
Galantamine—Hepatobiliary disease—Doxorubicin—liver cancer	0.00146	0.00207	CcSEcCtD
Galantamine—Epistaxis—Doxorubicin—liver cancer	0.00146	0.00206	CcSEcCtD
Galantamine—Visual impairment—Epirubicin—liver cancer	0.00144	0.00204	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—liver cancer	0.00141	0.002	CcSEcCtD
Galantamine—Eye disorder—Epirubicin—liver cancer	0.0014	0.00198	CcSEcCtD
Galantamine—Tinnitus—Epirubicin—liver cancer	0.0014	0.00198	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—liver cancer	0.00139	0.00197	CcSEcCtD
Galantamine—Flushing—Epirubicin—liver cancer	0.00139	0.00197	CcSEcCtD
Galantamine—Cardiac disorder—Epirubicin—liver cancer	0.00139	0.00197	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—liver cancer	0.00139	0.00197	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—liver cancer	0.00139	0.00196	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—liver cancer	0.00139	0.00196	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—liver cancer	0.00137	0.00194	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—liver cancer	0.00137	0.00193	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—liver cancer	0.00136	0.00193	CcSEcCtD
Galantamine—Angiopathy—Epirubicin—liver cancer	0.00136	0.00192	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—liver cancer	0.00136	0.00192	CcSEcCtD
Galantamine—Immune system disorder—Epirubicin—liver cancer	0.00135	0.00191	CcSEcCtD
Galantamine—Arrhythmia—Epirubicin—liver cancer	0.00134	0.00189	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—liver cancer	0.00134	0.00189	CcSEcCtD
Galantamine—Mental disorder—Epirubicin—liver cancer	0.00131	0.00186	CcSEcCtD
Galantamine—Malnutrition—Epirubicin—liver cancer	0.0013	0.00185	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—liver cancer	0.0013	0.00183	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—liver cancer	0.00129	0.00183	CcSEcCtD
Galantamine—Flushing—Doxorubicin—liver cancer	0.00129	0.00182	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—liver cancer	0.00129	0.00182	CcSEcCtD
Galantamine—Flatulence—Epirubicin—liver cancer	0.00129	0.00182	CcSEcCtD
Galantamine—Tension—Epirubicin—liver cancer	0.00128	0.00181	CcSEcCtD
Galantamine—Dysgeusia—Epirubicin—liver cancer	0.00128	0.00181	CcSEcCtD
Galantamine—Nervousness—Epirubicin—liver cancer	0.00127	0.00179	CcSEcCtD
Galantamine—Back pain—Epirubicin—liver cancer	0.00126	0.00179	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—liver cancer	0.00126	0.00178	CcSEcCtD
Galantamine—Muscle spasms—Epirubicin—liver cancer	0.00125	0.00177	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—liver cancer	0.00125	0.00177	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—liver cancer	0.00124	0.00175	CcSEcCtD
Galantamine—Vision blurred—Epirubicin—liver cancer	0.00123	0.00174	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—liver cancer	0.00121	0.00172	CcSEcCtD
Galantamine—Ill-defined disorder—Epirubicin—liver cancer	0.00121	0.00171	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—liver cancer	0.00121	0.00171	CcSEcCtD
Galantamine—Anaemia—Epirubicin—liver cancer	0.00121	0.00171	CcSEcCtD
Galantamine—Agitation—Epirubicin—liver cancer	0.0012	0.0017	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—liver cancer	0.00119	0.00168	CcSEcCtD
Galantamine—Tension—Doxorubicin—liver cancer	0.00118	0.00168	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—liver cancer	0.00118	0.00167	CcSEcCtD
Galantamine—Malaise—Epirubicin—liver cancer	0.00118	0.00166	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—liver cancer	0.00117	0.00166	CcSEcCtD
Galantamine—Vertigo—Epirubicin—liver cancer	0.00117	0.00166	CcSEcCtD
Galantamine—Syncope—Epirubicin—liver cancer	0.00117	0.00165	CcSEcCtD
Galantamine—Back pain—Doxorubicin—liver cancer	0.00117	0.00165	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—liver cancer	0.00116	0.00164	CcSEcCtD
Galantamine—Palpitations—Epirubicin—liver cancer	0.00115	0.00163	CcSEcCtD
Galantamine—Loss of consciousness—Epirubicin—liver cancer	0.00115	0.00162	CcSEcCtD
Galantamine—Cough—Epirubicin—liver cancer	0.00114	0.00161	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—liver cancer	0.00114	0.00161	CcSEcCtD
Galantamine—Convulsion—Epirubicin—liver cancer	0.00113	0.0016	CcSEcCtD
Galantamine—Hypertension—Epirubicin—liver cancer	0.00113	0.00159	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—liver cancer	0.00112	0.00158	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—liver cancer	0.00112	0.00158	CcSEcCtD
Galantamine—Myalgia—Epirubicin—liver cancer	0.00111	0.00157	CcSEcCtD
Galantamine—Chest pain—Epirubicin—liver cancer	0.00111	0.00157	CcSEcCtD
Galantamine—Arthralgia—Epirubicin—liver cancer	0.00111	0.00157	CcSEcCtD
Galantamine—Agitation—Doxorubicin—liver cancer	0.00111	0.00157	CcSEcCtD
Galantamine—Anxiety—Epirubicin—liver cancer	0.00111	0.00157	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.0011	0.00156	CcSEcCtD
Galantamine—Discomfort—Epirubicin—liver cancer	0.0011	0.00155	CcSEcCtD
Galantamine—Malaise—Doxorubicin—liver cancer	0.00109	0.00154	CcSEcCtD
Galantamine—Dry mouth—Epirubicin—liver cancer	0.00109	0.00154	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—liver cancer	0.00108	0.00153	CcSEcCtD
Galantamine—Syncope—Doxorubicin—liver cancer	0.00108	0.00153	CcSEcCtD
Galantamine—Confusional state—Epirubicin—liver cancer	0.00107	0.00152	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—liver cancer	0.00107	0.00151	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—liver cancer	0.00106	0.0015	CcSEcCtD
Galantamine—Cough—Doxorubicin—liver cancer	0.00105	0.00149	CcSEcCtD
Galantamine—Shock—Epirubicin—liver cancer	0.00105	0.00148	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—liver cancer	0.00105	0.00148	CcSEcCtD
Galantamine—Nervous system disorder—Epirubicin—liver cancer	0.00104	0.00148	CcSEcCtD
Galantamine—Thrombocytopenia—Epirubicin—liver cancer	0.00104	0.00147	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—liver cancer	0.00104	0.00147	CcSEcCtD
Galantamine—Tachycardia—Epirubicin—liver cancer	0.00104	0.00147	CcSEcCtD
Galantamine—Skin disorder—Epirubicin—liver cancer	0.00103	0.00146	CcSEcCtD
Galantamine—Hyperhidrosis—Epirubicin—liver cancer	0.00103	0.00146	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—liver cancer	0.00103	0.00145	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—liver cancer	0.00103	0.00145	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—liver cancer	0.00103	0.00145	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—liver cancer	0.00102	0.00145	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00102	0.00144	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—liver cancer	0.00102	0.00144	CcSEcCtD
Galantamine—Anorexia—Epirubicin—liver cancer	0.00101	0.00144	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—liver cancer	0.001	0.00142	CcSEcCtD
Galantamine—Hypotension—Epirubicin—liver cancer	0.000995	0.00141	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—liver cancer	0.000993	0.00141	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00097	0.00137	CcSEcCtD
Galantamine—Shock—Doxorubicin—liver cancer	0.000969	0.00137	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—liver cancer	0.000966	0.00137	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—liver cancer	0.000964	0.00136	CcSEcCtD
Galantamine—Insomnia—Epirubicin—liver cancer	0.000963	0.00136	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—liver cancer	0.000961	0.00136	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—liver cancer	0.000957	0.00135	CcSEcCtD
Galantamine—Paraesthesia—Epirubicin—liver cancer	0.000956	0.00135	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—liver cancer	0.000952	0.00135	CcSEcCtD
Galantamine—Somnolence—Epirubicin—liver cancer	0.000946	0.00134	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—liver cancer	0.000939	0.00133	CcSEcCtD
Galantamine—Dyspepsia—Epirubicin—liver cancer	0.000937	0.00133	CcSEcCtD
Galantamine—Decreased appetite—Epirubicin—liver cancer	0.000925	0.00131	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—liver cancer	0.00092	0.0013	CcSEcCtD
Galantamine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000919	0.0013	CcSEcCtD
Galantamine—Fatigue—Epirubicin—liver cancer	0.000918	0.0013	CcSEcCtD
Galantamine—Constipation—Epirubicin—liver cancer	0.00091	0.00129	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000897	0.00127	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—liver cancer	0.000891	0.00126	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—liver cancer	0.000885	0.00125	CcSEcCtD
Galantamine—Feeling abnormal—Epirubicin—liver cancer	0.000877	0.00124	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—liver cancer	0.000876	0.00124	CcSEcCtD
Galantamine—Gastrointestinal pain—Epirubicin—liver cancer	0.000871	0.00123	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—liver cancer	0.000867	0.00123	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—liver cancer	0.000856	0.00121	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00085	0.0012	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—liver cancer	0.000849	0.0012	CcSEcCtD
Galantamine—Constipation—Doxorubicin—liver cancer	0.000842	0.00119	CcSEcCtD
Galantamine—Body temperature increased—Epirubicin—liver cancer	0.000842	0.00119	CcSEcCtD
Galantamine—Abdominal pain—Epirubicin—liver cancer	0.000842	0.00119	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—liver cancer	0.000812	0.00115	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000806	0.00114	CcSEcCtD
Galantamine—Hypersensitivity—Epirubicin—liver cancer	0.000784	0.00111	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—liver cancer	0.000779	0.0011	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—liver cancer	0.000779	0.0011	CcSEcCtD
Galantamine—Asthenia—Epirubicin—liver cancer	0.000764	0.00108	CcSEcCtD
Galantamine—Diarrhoea—Epirubicin—liver cancer	0.000728	0.00103	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—liver cancer	0.000726	0.00103	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—liver cancer	0.000707	0.001	CcSEcCtD
Galantamine—Dizziness—Epirubicin—liver cancer	0.000704	0.000996	CcSEcCtD
Galantamine—Vomiting—Epirubicin—liver cancer	0.000677	0.000958	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—liver cancer	0.000674	0.000954	CcSEcCtD
Galantamine—Rash—Epirubicin—liver cancer	0.000671	0.00095	CcSEcCtD
Galantamine—Dermatitis—Epirubicin—liver cancer	0.000671	0.000949	CcSEcCtD
Galantamine—Headache—Epirubicin—liver cancer	0.000667	0.000944	CcSEcCtD
Galantamine—Dizziness—Doxorubicin—liver cancer	0.000651	0.000922	CcSEcCtD
Galantamine—Nausea—Epirubicin—liver cancer	0.000632	0.000895	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—liver cancer	0.000626	0.000886	CcSEcCtD
Galantamine—Rash—Doxorubicin—liver cancer	0.000621	0.000879	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—liver cancer	0.000621	0.000878	CcSEcCtD
Galantamine—Headache—Doxorubicin—liver cancer	0.000617	0.000873	CcSEcCtD
Galantamine—Nausea—Doxorubicin—liver cancer	0.000585	0.000828	CcSEcCtD
Galantamine—CHRNA2—Neuronal System—RAF1—liver cancer	0.00027	0.000921	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000269	0.000919	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000268	0.000913	CbGpPWpGaD
Galantamine—BCHE—Metabolism—UGDH—liver cancer	0.000267	0.00091	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TAT—liver cancer	0.000267	0.000909	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000266	0.000906	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—HRAS—liver cancer	0.000263	0.000896	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000262	0.000894	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.000261	0.00089	CbGpPWpGaD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000258	0.00088	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CB—liver cancer	0.000255	0.000871	CbGpPWpGaD
Galantamine—BCHE—Metabolism—EPT1—liver cancer	0.000251	0.000856	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000249	0.000849	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000246	0.00084	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000246	0.000838	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—liver cancer	0.000243	0.00083	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000243	0.000829	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—liver cancer	0.000241	0.000822	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—HRAS—liver cancer	0.00024	0.000819	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.00024	0.000819	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ATF3—liver cancer	0.000239	0.000816	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TAT—liver cancer	0.000238	0.000811	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—HRAS—liver cancer	0.000238	0.000811	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—RAF1—liver cancer	0.000234	0.000798	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000234	0.000798	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.000233	0.000794	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000232	0.00079	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—HRAS—liver cancer	0.000231	0.000789	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000229	0.000781	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000228	0.000779	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000226	0.000771	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000226	0.000771	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000225	0.000768	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000224	0.000763	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.000218	0.000743	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000217	0.000742	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ATF3—liver cancer	0.000213	0.000728	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GGT1—liver cancer	0.00021	0.000715	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000207	0.000706	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—HRAS—liver cancer	0.000206	0.000704	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000204	0.000696	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000203	0.000692	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000202	0.000689	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—BRAF—liver cancer	0.0002	0.000682	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000198	0.000674	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000197	0.000673	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—liver cancer	0.000196	0.00067	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000196	0.000669	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000196	0.000667	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.000194	0.000663	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000194	0.000662	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000192	0.000655	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000191	0.000652	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.000188	0.000642	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000187	0.000636	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000186	0.000633	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—HRAS—liver cancer	0.000184	0.000628	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000183	0.000625	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—HRAS—liver cancer	0.000182	0.000621	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GLUL—liver cancer	0.000181	0.000618	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CPT1B—liver cancer	0.000181	0.000618	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—BRAF—liver cancer	0.000178	0.000608	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000175	0.000597	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NR1H4—liver cancer	0.000175	0.000596	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CA—liver cancer	0.000174	0.000595	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000173	0.00059	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000172	0.000588	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTA3—liver cancer	0.000172	0.000586	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000171	0.000582	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—HRAS—liver cancer	0.000168	0.000574	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—RAF1—liver cancer	0.000167	0.000569	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—HRAS—liver cancer	0.000167	0.000568	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000164	0.000559	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000162	0.000552	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GLUL—liver cancer	0.000162	0.000551	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CPT1B—liver cancer	0.000162	0.000551	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000158	0.000541	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000158	0.000539	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—HRAS—liver cancer	0.000158	0.000539	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTA4—liver cancer	0.000157	0.000536	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—HRAS—liver cancer	0.000156	0.000534	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NR1H4—liver cancer	0.000156	0.000532	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—liver cancer	0.000156	0.000531	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000154	0.000524	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA3—liver cancer	0.000153	0.000523	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTA2—liver cancer	0.000153	0.000522	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000149	0.000509	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—RAF1—liver cancer	0.000149	0.000508	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—HRAS—liver cancer	0.000149	0.000507	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF2—liver cancer	0.000148	0.000506	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTA1—liver cancer	0.000148	0.000504	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000148	0.000504	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000147	0.000502	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000146	0.0005	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NAT2—liver cancer	0.000146	0.000498	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00014	0.000479	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA4—liver cancer	0.00014	0.000478	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALDOB—liver cancer	0.00014	0.000478	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000137	0.000467	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000137	0.000467	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA2—liver cancer	0.000137	0.000466	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000135	0.000459	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CRABP1—liver cancer	0.000134	0.000456	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF2—liver cancer	0.000132	0.000451	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTA1—liver cancer	0.000132	0.000449	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NAT2—liver cancer	0.00013	0.000444	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.00013	0.000444	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—HRAS—liver cancer	0.000129	0.00044	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000125	0.000427	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALDOB—liver cancer	0.000125	0.000426	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000123	0.00042	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UGDH—liver cancer	0.000123	0.000418	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000121	0.000414	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.00012	0.00041	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.00012	0.000409	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CRABP1—liver cancer	0.000119	0.000406	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HPGDS—liver cancer	0.000117	0.000398	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000116	0.000396	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—EPT1—liver cancer	0.000115	0.000393	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000113	0.000386	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000112	0.000381	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.00011	0.000375	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TAT—liver cancer	0.000109	0.000373	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—F2—liver cancer	0.000109	0.00037	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000107	0.000366	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000107	0.000366	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000107	0.000365	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000106	0.000361	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000106	0.000361	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000104	0.000356	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HPGDS—liver cancer	0.000104	0.000355	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PSMA4—liver cancer	0.000104	0.000355	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PSMD10—liver cancer	0.000104	0.000355	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000104	0.000353	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GOT2—liver cancer	0.000101	0.000345	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—F2—liver cancer	9.69e-05	0.00033	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2E1—liver cancer	9.52e-05	0.000325	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.43e-05	0.000322	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.31e-05	0.000318	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PSMA4—liver cancer	9.28e-05	0.000317	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PSMD10—liver cancer	9.28e-05	0.000317	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.22e-05	0.000314	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—liver cancer	9.21e-05	0.000314	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—liver cancer	9.19e-05	0.000314	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GOT2—liver cancer	9.03e-05	0.000308	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYCS—liver cancer	8.91e-05	0.000304	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GOT1—liver cancer	8.74e-05	0.000298	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GGT1—liver cancer	8.74e-05	0.000298	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2E1—liver cancer	8.49e-05	0.00029	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.22e-05	0.00028	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—liver cancer	8.21e-05	0.00028	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—liver cancer	8.2e-05	0.00028	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UGDH—liver cancer	8.02e-05	0.000274	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYCS—liver cancer	7.94e-05	0.000271	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—liver cancer	7.85e-05	0.000268	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GOT1—liver cancer	7.8e-05	0.000266	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GGT1—liver cancer	7.8e-05	0.000266	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—liver cancer	7.74e-05	0.000264	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—EPT1—liver cancer	7.54e-05	0.000257	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CPT1B—liver cancer	7.43e-05	0.000254	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GLUL—liver cancer	7.43e-05	0.000254	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—liver cancer	7.21e-05	0.000246	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NR1H4—liver cancer	7.17e-05	0.000244	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TAT—liver cancer	7.15e-05	0.000244	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CTNNB1—liver cancer	7.06e-05	0.000241	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA3—liver cancer	7.05e-05	0.00024	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—liver cancer	7e-05	0.000239	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—liver cancer	6.91e-05	0.000236	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A1—liver cancer	6.84e-05	0.000233	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA4—liver cancer	6.44e-05	0.00022	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—liver cancer	6.43e-05	0.00022	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—liver cancer	6.37e-05	0.000217	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTNNB1—liver cancer	6.3e-05	0.000215	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA2—liver cancer	6.28e-05	0.000214	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARA—liver cancer	6.25e-05	0.000213	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A1—liver cancer	6.1e-05	0.000208	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTA1—liver cancer	6.06e-05	0.000207	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NAT2—liver cancer	5.99e-05	0.000204	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALDOB—liver cancer	5.74e-05	0.000196	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—liver cancer	5.69e-05	0.000194	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.62e-05	0.000192	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARA—liver cancer	5.58e-05	0.00019	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CRABP1—liver cancer	5.48e-05	0.000187	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—liver cancer	5.36e-05	0.000183	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—liver cancer	5.17e-05	0.000176	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.01e-05	0.000171	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CPT1B—liver cancer	4.86e-05	0.000166	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GLUL—liver cancer	4.86e-05	0.000166	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HPGDS—liver cancer	4.79e-05	0.000163	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—liver cancer	4.78e-05	0.000163	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CD—liver cancer	4.71e-05	0.000161	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NR1H4—liver cancer	4.69e-05	0.00016	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—liver cancer	4.65e-05	0.000159	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—liver cancer	4.61e-05	0.000157	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA3—liver cancer	4.61e-05	0.000157	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PSMA4—liver cancer	4.27e-05	0.000146	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PSMD10—liver cancer	4.27e-05	0.000146	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA4—liver cancer	4.21e-05	0.000144	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CD—liver cancer	4.2e-05	0.000143	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GOT2—liver cancer	4.15e-05	0.000142	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—liver cancer	4.15e-05	0.000141	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA2—liver cancer	4.11e-05	0.00014	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CB—liver cancer	4.1e-05	0.00014	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTA1—liver cancer	3.96e-05	0.000135	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NAT2—liver cancer	3.92e-05	0.000134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2E1—liver cancer	3.9e-05	0.000133	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALDOB—liver cancer	3.75e-05	0.000128	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CB—liver cancer	3.66e-05	0.000125	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYCS—liver cancer	3.65e-05	0.000125	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GGT1—liver cancer	3.58e-05	0.000122	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GOT1—liver cancer	3.58e-05	0.000122	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CRABP1—liver cancer	3.58e-05	0.000122	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—liver cancer	3.22e-05	0.00011	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—liver cancer	3.18e-05	0.000108	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HPGDS—liver cancer	3.13e-05	0.000107	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—liver cancer	2.96e-05	0.000101	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.8e-05	9.57e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PSMA4—liver cancer	2.79e-05	9.52e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PSMD10—liver cancer	2.79e-05	9.52e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GOT2—liver cancer	2.71e-05	9.26e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—liver cancer	2.61e-05	8.92e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARA—liver cancer	2.57e-05	8.75e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.55e-05	8.71e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—liver cancer	2.5e-05	8.53e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYCS—liver cancer	2.39e-05	8.15e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GOT1—liver cancer	2.34e-05	7.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GGT1—liver cancer	2.34e-05	7.99e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—liver cancer	2.23e-05	7.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—liver cancer	2.2e-05	7.49e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—liver cancer	2.12e-05	7.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—liver cancer	2.1e-05	7.18e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—liver cancer	2.08e-05	7.08e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—liver cancer	2.04e-05	6.97e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—liver cancer	1.93e-05	6.6e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.93e-05	6.59e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—liver cancer	1.91e-05	6.5e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.83e-05	6.26e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—liver cancer	1.82e-05	6.22e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—liver cancer	1.71e-05	5.83e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.68e-05	5.74e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARA—liver cancer	1.68e-05	5.72e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.44e-05	4.9e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—liver cancer	1.39e-05	4.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.26e-05	4.31e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—liver cancer	1.25e-05	4.25e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.1e-05	3.75e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.03e-05	3.5e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—liver cancer	8.38e-06	2.86e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—liver cancer	6.71e-06	2.29e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—liver cancer	5.48e-06	1.87e-05	CbGpPWpGaD
